Literature DB >> 21621407

The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody.

Yohei Saito1, Yuki Hashimoto, Jun-ichiro Kuroda, Masahiro Yasunaga, Yoshikatsu Koga, Amane Takahashi, Yasuhiro Matsumura.   

Abstract

Tissue factor (TF), the initiating cell surface receptor for the blood coagulation cascade, plays an important role in malignant transformation of the pancreas, although the precise mechanism remains unresolved. Here, we report that the TF - factor VIIa complex in human pancreatic cancer cells produced a significant amount of MMP-9 and promoted invasion ability in vitro and invasion and metastasis in vivo. For treatment, we successfully developed an anti-human TF monoclonal antibody that inhibits both cellular signalling and blood coagulation cascade via TF. Invasive capability and MMP-9 expression were significantly reduced by the antibody. The antibody inhibited not only tumour invasion in the orthotopic model, but also haematogenous metastasis in the portal-injection liver metastasis model. In conclusion, the TF-VIIa complex plays an important role in invasion-metastasis by enhancing tumour cell infiltration ability and forming microthrombi. The newly established anti-human TF neutralisation antibody may be useful for the treatment of pancreatic and other invasive cancers.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21621407     DOI: 10.1016/j.ejca.2011.04.028

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

1.  Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma.

Authors:  Faruk Tas; Senem Karabulut; Elif Bilgin; Leyla Kılıc; Rumeysa Ciftci; Derya Duranyildiz
Journal:  J Gastrointest Cancer       Date:  2013-12

2.  Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells.

Authors:  Fang Liu; Murray Korc
Journal:  Mol Cancer Ther       Date:  2012-08-06       Impact factor: 6.261

3.  Modeling and simulation of procoagulant circulating tumor cells in flow.

Authors:  Angela M Lee; Garth W Tormoen; Eva Kanso; Owen J T McCarty; Paul K Newton
Journal:  Front Oncol       Date:  2012-09-14       Impact factor: 6.244

4.  Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.

Authors:  Yoshiyuki Yamamoto; Ichinosuke Hyodo; Yoshikatsu Koga; Ryo Tsumura; Ryuta Sato; Toshihumi Obonai; Hirobumi Fuchigami; Fumiaki Furuya; Masahiro Yasunaga; Mitsunori Harada; Yasuki Kato; Atsushi Ohtsu; Yasuhiro Matsumura
Journal:  Cancer Sci       Date:  2015-03-23       Impact factor: 6.716

5.  Role of SLC6A6 in promoting the survival and multidrug resistance of colorectal cancer.

Authors:  Masahiro Yasunaga; Yasuhiro Matsumura
Journal:  Sci Rep       Date:  2014-04-30       Impact factor: 4.379

6.  Antitumor effect of antitissue factor antibody-MMAE conjugate in human pancreatic tumor xenografts.

Authors:  Yoshikatsu Koga; Shino Manabe; Yoshiyuki Aihara; Ryuta Sato; Ryo Tsumura; Hikaru Iwafuji; Fumiaki Furuya; Hirobumi Fuchigami; Yuki Fujiwara; Yohei Hisada; Yoshiyuki Yamamoto; Masahiro Yasunaga; Yasuhiro Matsumura
Journal:  Int J Cancer       Date:  2015-03-09       Impact factor: 7.396

7.  Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model.

Authors:  Hiroki Takashima; Atsushi B Tsuji; Tsuneo Saga; Masahiro Yasunaga; Yoshikatsu Koga; Jun-Ichiro Kuroda; Shigetoshi Yano; Jun-Ichi Kuratsu; Yasuhiro Matsumura
Journal:  Sci Rep       Date:  2017-09-26       Impact factor: 4.379

8.  Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma.

Authors:  Xuesai Zhang; Qingrou Li; Hui Zhao; Lanping Ma; Tao Meng; Jianchang Qian; Rui Jin; Jingkang Shen; Ker Yu
Journal:  Oncotarget       Date:  2017-07-10

Review 9.  Tissue factor in tumor microenvironment: a systematic review.

Authors:  Xiao Han; Bo Guo; Yongsheng Li; Bo Zhu
Journal:  J Hematol Oncol       Date:  2014-08-01       Impact factor: 17.388

10.  Utility of epirubicin-incorporating micelles tagged with anti-tissue factor antibody clone with no anticoagulant effect.

Authors:  Akinori Sugaya; Ichinosuke Hyodo; Yoshikatsu Koga; Yoshiyuki Yamamoto; Hiroki Takashima; Ryuta Sato; Ryo Tsumura; Fumiaki Furuya; Masahiro Yasunaga; Mitsunori Harada; Ryosuke Tanaka; Yasuhiro Matsumura
Journal:  Cancer Sci       Date:  2016-02-09       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.